News

Telsey Advisory Reduces PT on Burlington Stores (BURL) Stock, Maintains Outperform Rating
On May 30, Telsey Advisory Group reduced its price objective on Burlington Stores, Inc. (NYSE: BURL )’s stock to $300 from ...
These 10 Stocks Just Rocked The Market
Ten companies posted a sluggish performance last week, with investor sentiment weighed down by a wave of negative ...
Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Jim Cramer on D-Wave Quantum (QBTS): “Of the Ones That Are Out There, This is the Best”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Jim Cramer on BigBear.ai Holdings (BBAI): “I’m Going to Suggest Palantir”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Jim Cramer on Verizon Communications Inc. (VZ): “They’re Doing Better”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Jim Cramer Says Buy DICK’S Sporting Goods (DKS) Sporting Goods”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...
Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial
Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at ...
Actuate Therapeutics, Inc. (ACTU)’s Elraglusib Elraglusib Trial Hits Key Goals in Pancreatic Cancer
Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined ...